Pomalidomide

CHEMBL43452 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

273.2 g/mol

LogP

0.2

Phase

4

A medication related to thalidomide used to treat multiple myeloma that has stopped responding to other treatments, working by stimulating the immune system to attack cancer cells while also interfering with cancer cell growth. It must be used with strict pregnancy prevention measures due to severe risk of birth defects.

Peso Molecular

273,2400 g/mol

LogP

0,20

TPSA

110,00 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Lymphoma Breast Cancer Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O

InChI

InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)

Molecular Formula

C13H11N3O4

HBD / HBA

2 / 5

Ligações Rotacionáveis

1

Átomos Pesados

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A medication related to thalidomide used to treat multiple myeloma that has stopped responding to other treatments, working by stimulating the immune system to attack cancer cells while also interfering with cancer cell growth. It must be used with strict pregnancy prevention measures due to severe risk of birth defects.

Yes, Pomalidomide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL43452. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 134780. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Pomalidomide no PillFYI

Estrutura

Dados Rápidos

Fórmula: C13H11N3O4
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.